Decision
PLGB numbers for the grandfathering of CAP MAs
Updated 24 March 2022
Download CSV 205 KB
| Product | PLGB MAH | PLGB |
|---|---|---|
| Exviera 250 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0023 |
| Humira 20 mg - Solution for injection | AbbVie Ltd | PLGB 41042/0024 |
| Humira 40 mg - Solution for injection | AbbVie Ltd | PLGB 41042/0025 |
| Humira 80 mg - Solution for injection | AbbVie Ltd | PLGB 41042/0026 |
| Kaletra 100 mg + 25 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0027 |
| Kaletra 200 mg + 50 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0028 |
| Kaletra 80 mg/ml + 20 mg/ml - Oral solution | AbbVie Ltd | PLGB 41042/0029 |
| Maviret 100 mg + 40 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0030 |
| Norvir 100 mg - Powder for oral suspension | AbbVie Ltd | PLGB 41042/0031 |
| Norvir 100 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0032 |
| Skyrizi 75 mg Solution for injection | AbbVie Ltd | PLGB 41042/0033 |
| Synagis 100 mg/ml - Solution for injection | AbbVie Ltd | PLGB 41042/0034 |
| Venclyxto 10 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0035 |
| Venclyxto 100 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0036 |
| Venclyxto 50 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0037 |
| Viekirax 12.5 mg + 75 mg + 50 mg - Film-coated tablet | AbbVie Ltd | PLGB 41042/0038 |
| RINVOQ 15 mg prolonged-release tablets | AbbVie Ltd | PLGB 41042/0042 |
| Cablivi 10 mg Powder and solvent for solution for injection | Aventis Pharma Limited | PLGB 04425/0888 |
| Accofil 30 MU/0.5 ml - Solution for injection/infusion | Accord Healthcare Limited | PLGB 20075/1258 |
| Accofil 48 MU/0.5 ml - Solution for injection/infusion | Accord Healthcare Limited | PLGB 20075/1259 |
| Aripiprazole Accord 10 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1261 |
| Aripiprazole Accord 15 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1262 |
| Aripiprazole Accord 30 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1263 |
| Aripiprazole Accord 5 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1260 |
| Bortezomib Accord 1 mg - Powder for solution for injection | Accord Healthcare Limited | PLGB 20075/1264 |
| Bortezomib Accord 3.5 mg - Powder for solution for injection | Accord Healthcare Limited | PLGB 20075/1265 |
| Capecitabine Accord 150 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1266 |
| Capecitabine Accord 300 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1267 |
| Capecitabine Accord 500 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1268 |
| Docetaxel Accord 160 mg/8 ml - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1271 |
| Docetaxel Accord 20 mg/1 ml - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1272 |
| Docetaxel Accord 80 mg/4 ml - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1273 |
| Entecavir Accord 0.5 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1274 |
| Entecavir Accord 1 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1275 |
| Eptifibatide Accord 0.75 mg/ml - Solution for infusion | Accord Healthcare Limited | PLGB 20075/1276 |
| Eptifibatide Accord 2 mg/ml - Solution for injection | Accord Healthcare Limited | PLGB 20075/1277 |
| Granpidam 20 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1278 |
| Ibandronic acid Accord 2 mg - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1279 |
| Ibandronic acid Accord 3 mg - Solution for injection | Accord Healthcare Limited | PLGB 20075/1281 |
| Ibandronic acid Accord 6 mg - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1280 |
| Imatinib Accord 100 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1282 |
| Imatinib Accord 400 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1283 |
| Ivabradine Accord 5 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1284 |
| Ivabradine Accord 7.5 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1285 |
| Lacosamide Accord 100 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1287 |
| Lacosamide Accord 150 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1288 |
| Lacosamide Accord 200 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1289 |
| Lacosamide Accord 50 / 100 / 150 / 200 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1290 |
| Lacosamide Accord 50 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1286 |
| Lenalidomide Accord 10 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1294 |
| Lenalidomide Accord 15 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1295 |
| Lenalidomide Accord 2.5 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1291 |
| Lenalidomide Accord 20 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1296 |
| Lenalidomide Accord 25 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1297 |
| Lenalidomide Accord 5 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1292 |
| Lenalidomide Accord 7.5 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1293 |
| Levetiracetam Accord 1000 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1301 |
| Levetiracetam Accord 250 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1298 |
| Levetiracetam Accord 500 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1299 |
| Levetiracetam Accord 750 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1300 |
| Memantine Accord 10 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1302 |
| Memantine Accord 20 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1303 |
| Memantine Accord 5 mg + 10 mg + 15 mg + 20 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1304 |
| Palonosetron Accord 250 µg - Solution for injection | Accord Healthcare Limited | PLGB 20075/1305 |
| Pelgraz 6 mg - Solution for injection | Accord Healthcare Limited | PLGB 20075/1306 |
| Pemetrexed Accord 100 mg - Powder for concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1307 |
| Pemetrexed Accord 1000 mg - Powder for concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1309 |
| Pemetrexed Accord 500 mg - Powder for concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1308 |
| Pioglitazone Accord 15 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1310 |
| Pioglitazone Accord 30 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1311 |
| Pioglitazone Accord 45 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1312 |
| Pramipexole Accord 0.088 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1313 |
| Pramipexole Accord 0.18 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1314 |
| Pramipexole Accord 0.35 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1315 |
| Pramipexole Accord 0.7 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1316 |
| Pramipexole Accord 1.1 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1317 |
| Pregabalin Accord 100 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1321 |
| Pregabalin Accord 150 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1319 |
| Pregabalin Accord 200 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1323 |
| Pregabalin Accord 225 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1324 |
| Pregabalin Accord 25 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1318 |
| Pregabalin Accord 300 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1325 |
| Pregabalin Accord 50 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1319 |
| Pregabalin Accord 75 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1320 |
| Repaglinide Accord 0.5 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1326 |
| Repaglinide Accord 1 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1327 |
| Repaglinide Accord 2 mg - Tablet | Accord Healthcare Limited | PLGB 20075/1328 |
| Temozolomide Accord 100 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1331 |
| Temozolomide Accord 140 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1332 |
| Temozolomide Accord 180 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1333 |
| Temozolomide Accord 20 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1330 |
| Temozolomide Accord 250 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1334 |
| Temozolomide Accord 5 mg - Capsule, hard | Accord Healthcare Limited | PLGB 20075/1329 |
| Voriconazole Accord 200 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1336 |
| Voriconazole Accord 50 mg - Film-coated tablet | Accord Healthcare Limited | PLGB 20075/1335 |
| Zoledronic Acid Accord 4 mg/5 ml - Concentrate for solution for infusion | Accord Healthcare Limited | PLGB 20075/1337 |
| Inbrija inhalation powder hard capsules | Acorda Therapeutics Ireland Limited | PLGB 51169/0001 |
| Ebilfumin 30 mg - Capsule, hard | Teva UK Limited | PLGB 00289/2346 |
| Ebilfumin 45 mg - Capsule, hard | Teva UK Limited | PLGB 00289/2347 |
| Ebilfumin 75 mg - Capsule, hard | Teva UK Limited | PLGB 00289/2348 |
| Imatinib Actavis 100 mg - Capsule, hard | Accord UK Limited | PLGB 00142/1134 |
| Imatinib Actavis 400 mg - Capsule, hard | Accord UK Limited | PLGB 00142/1136 |
| Imatinib Actavis 50 mg - Capsule, hard | Accord UK Limited | PLGB 00142/1138 |
| Nemdatine 10 mg - Film-coated tablet | Accord UK Limited | PLGB 00142/1144 |
| Nemdatine 15 mg - Film-coated tablet | Accord UK Limited | PLGB 00142/1145 |
| Nemdatine 20 mg - Film-coated tablet | Accord UK Limited | PLGB 00142/1146 |
| Nemdatine 5 mg - Film-coated tablet | Accord UK Limited | PLGB 00142/1147 |
| Nemdatine 5 mg + 10 mg + 15 mg + 20 mg - Film-coated tablet | Accord UK Limited | PLGB 00142/1148 |
| Rapilysin 10 U - Powder and solvent for solution for injection | Accord UK Limited | PLGB 00142/1149 |
| Siklos 100 mg - Film-coated tablet | Addmedica S.A.S. | PLGB 36580/0002 |
| Siklos 1000 mg - Film-coated tablet | Addmedica S.A.S. | PLGB 36580/0003 |
| Tepadina 100 mg - Powder for solution for infusion | ADIENNE S.r.l. | PLGB 40008/0002 |
| Tepadina 15 mg - Powder for solution for infusion | ADIENNE S.r.l. | PLGB 40008/0003 |
| LUTATHERA 370 MBq/ml - Solution for infusion | Advanced Accelerator Applications | PLGB 35145/0003 |
| SomaKit TOC 40 micrograms - Kit for radiopharmaceutical preparation | Advanced Accelerator Applications | PLGB 35145/0004 |
| LysaKare 25g/25g solution for infusion | Advanced Accelerator Applications | PLGB 35145/0005 |
| Macimorelin Aeterna Zentaris | Aeterna Zentaris | PLGB 33231/0002 |
| Tegsedi 284 mg Solution for injection | Akcea Therapeutics Ireland Limited | PLGB 51704/0002 |
| Waylivra 285mg Solution for injection | Akcea Therapeutics Ireland Limited | PLGB 51704/0003 |
| Ultomiris 300mg/30 mL Concentrate for solution for infusion | Alexion Europe SAS | PLGB 31187/0019 |
| Kanuma 2 mg/ml Concentrate for solution for infusion | Alexion Europe SAS | PLGB 31187/0017 |
| Soliris 300 mg - Concentrate for solution for infusion | Alexion Europe SAS | PLGB 31187/0020 |
| Strensiq 100 mg/ml - Solution for injection | Alexion Europe SAS | PLGB 31187/0004 |
| Strensiq 40 mg/ml - Solution for injection | Alexion Europe SAS | PLGB 31187/0005 |
| Eurartesim 20 mg + 160 mg - Film-coated tablet | Alfasigma S.p.A. | PLGB 48053/0016 |
| Eurartesim 40 mg + 320 mg - Film-coated tablet | Alfasigma S.p.A. | PLGB 48053/0017 |
| Constella 290 µg - Capsule, hard | Allergan Pharmaceuticals International Limited | PLGB 45496/0013 |
| Xydalba 500 mg - Powder for concentrate for solution for infusion | Allergan Pharmaceuticals International Limited | PLGB 45496/0014 |
| Ganfort 0.3 mg/ml + 5 mg/ml - Eye drops, solution bottle | Allergan Pharmaceuticals Ireland | PLGB 41443/0013 |
| Ganfort 0.3 mg/ml + 5 mg/ml - Eye drops, solution single does unit | Allergan Pharmaceuticals Ireland | PLGB 41443/0014 |
| Lumigan 0.1 mg/ml - Eye drops, solution | Allergan Pharmaceuticals Ireland | PLGB 41443/0015 |
| Lumigan 0.3 mg/ml - Eye drops, solution bottle | Allergan Pharmaceuticals Ireland | PLGB 41443/0016 |
| Lumigan 0.3 mg/ml - Eye drops, solution Single dose unit | Allergan Pharmaceuticals Ireland | PLGB 41443/0017 |
| Ozurdex 700 µg - Intravitreal implant in applicator | Allergan Pharmaceuticals Ireland | PLGB 41443/0018 |
| Ilumetri 100 mg - Solution for injection | Almirall Limited | PLGB 32511/0001 |
| Skilarence 120 mg - Gastro-resistant tablet | Almirall Limited | PLGB 32511/0002 |
| Skilarence 30 mg - Gastro-resistant tablet | Almirall Limited | PLGB 32511/0003 |
| Vaniqa 11.5% - Cream | Almirall Limited | PLGB 32511/0004 |
| Onpattro 2 mg/ml - Concentrate for solution for infusion | Alnylam Netherlands B.V. | PLGB 43942/0002 |
| AMGEVITA 20 mg - Solution for injection | Amgen Limited | PLGB 13832/0001 |
| AMGEVITA 40 mg - Solution for injection | Amgen Limited | PLGB 13832/0002 |
| Aranesp 10 µg - Solution for injection | Amgen Limited | PLGB 13832/0003 |
| Aranesp 100 µg - Solution for injection | Amgen Limited | PLGB 13832/0004 |
| Aranesp 130 µg - Solution for injection | Amgen Limited | PLGB 13832/0005 |
| Aranesp 15 µg - Solution for injection | Amgen Limited | PLGB 13832/0006 |
| Aranesp 150 µg - Solution for injection | Amgen Limited | PLGB 13832/0007 |
| Aranesp 20 µg - Solution for injection | Amgen Limited | PLGB 13832/0008 |
| Aranesp 200 µg - Solution for injection | Amgen Limited | PLGB 13832/0009 |
| Aranesp 25 µg - Solution for injection | Amgen Limited | PLGB 13832/0010 |
| Aranesp 30 µg - Solution for injection | Amgen Limited | PLGB 13832/0011 |
| Aranesp 300 µg - Solution for injection | Amgen Limited | PLGB 13832/0012 |
| Aranesp 40 µg - Solution for injection | Amgen Limited | PLGB 13832/0013 |
| Aranesp 50 µg - Solution for injection | Amgen Limited | PLGB 13832/0014 |
| Aranesp 500 µg - Solution for injection | Amgen Limited | PLGB 13832/0015 |
| Aranesp 60 µg - Solution for injection | Amgen Limited | PLGB 13832/0016 |
| Aranesp 80 µg - Solution for injection | Amgen Limited | PLGB 13832/0017 |
| BLINCYTO 38.5 µg - Powder for concentrate and solution for solution for infusion | Amgen Limited | PLGB 13832/0018 |
| Imlygic 1x 10e6 PFU/ml - Solution for injection | Amgen Limited | PLGB 13832/0019 |
| Imlygic 1x 10e8 PFU/ml - Solution for injection | Amgen Limited | PLGB 13832/0020 |
| KANJINTI 150 mg Powder for concentrate for solution for infusion | Amgen Limited | PLGB 13832/0021 |
| KANJINTI 420 mg Powder for concentrate for solution for infusion | Amgen Limited | PLGB 13832/0022 |
| Kyprolis 10 mg - Powder for solution for infusion | Amgen Limited | PLGB 13832/0023 |
| Kyprolis 30 mg - Powder for solution for infusion | Amgen Limited | PLGB 13832/0024 |
| Kyprolis 60 mg - Powder for solution for infusion | Amgen Limited | PLGB 13832/0025 |
| Mimpara 1 mg - Capsule, hard | Amgen Limited | PLGB 13832/0026 |
| Mimpara 2.5 mg - Capsule, hard | Amgen Limited | PLGB 13832/0027 |
| Mimpara 30 mg - Film-coated tablet | Amgen Limited | PLGB 13832/0028 |
| Mimpara 5 mg - Capsule, hard | Amgen Limited | PLGB 13832/0029 |
| Mimpara 60 mg - Film-coated tablet | Amgen Limited | PLGB 13832/0030 |
| Mimpara 90 mg - Film-coated tablet | Amgen Limited | PLGB 13832/0031 |
| MVASI 25 mg/ml - Concentrate for solution for infusion | Amgen Limited | PLGB 13832/0032 |
| Neulasta 6 mg - Solution for injection | Amgen Limited | PLGB 13832/0033 |
| Nplate 125 µg - Powder for solution for injection | Amgen Limited | PLGB 13832/0034 |
| Nplate 250 µg - Powder and solvent for solution for injection | Amgen Limited | PLGB 13832/0035 |
| Nplate 250 µg - Powder for solution for injection | Amgen Limited | PLGB 13832/0036 |
| Nplate 500 µg - Powder and solvent for solution for injection | Amgen Limited | PLGB 13832/0037 |
| Nplate 500 µg - Powder for solution for injection | Amgen Limited | PLGB 13832/0038 |
| Parsabiv 10 mg - Solution for injection | Amgen Limited | PLGB 13832/0039 |
| Parsabiv 2.5 mg - Solution for injection | Amgen Limited | PLGB 13832/0040 |
| Parsabiv 5 mg - Solution for injection | Amgen Limited | PLGB 13832/0041 |
| Prolia 60 mg/ml - Solution for injection | Amgen Limited | PLGB 13832/0042 |
| Repatha 140 mg - Solution for injection in pre-filled syringe | Amgen Limited | PLGB 13832/0043 |
| Repatha 420 mg - Solution for injection | Amgen Limited | PLGB 13832/0044 |
| Vectibix 20 mg/ml - Concentrate for solution for infusion | Amgen Limited | PLGB 13832/0045 |
| XGEVA 120 mg - Solution for injection | Amgen Limited | PLGB 13832/0046 |
| Galafold 123 mg - Capsule, hard | Amicus Therapeutics UK Ltd | PLGB 25823/0002 |
| Amglidia 0.6 mg/ml - Oral suspension 1 bottle + 1 bottle adapter + 1 ml oral syringe | Ammtek | PLGB 50687/0001 |
| Amglidia 6 mg/ml - Oral suspension 1 bottle + 1 bottle adapter + 1 ml oral syringe | Ammtek | PLGB 50687/0002 |
| Amglidia 0.6 mg/ml - Oral suspension 1 bottle + 1 bottle adapter + 5ml oral syringe | Ammtek | PLGB 50687/0003 |
| Amglidia 6 mg/ml - Oral suspension 1 bottle + 1 bottle adapter + 5ml oral syringe | Ammtek | PLGB 50687/0004 |
| Episalvan - Gel | Amryt AG | PLGB 41205/0001 |
| Myalepta 11.3 mg - Powder for solution for injection | Amryt Pharmaceuticals DAC | PLGB 50688/0008 |
| Myalepta 3 mg - Powder for solution for injection | Amryt Pharmaceuticals DAC | PLGB 50688/0009 |
| Myalepta 5.8 mg - Powder for solution for injection | Amryt Pharmaceuticals DAC | PLGB 50688/0010 |
| Lojuxta 10 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0001 |
| Lojuxta 20 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0002 |
| Lojuxta 30 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0003 |
| Lojuxta 40 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0004 |
| Lojuxta 5 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0005 |
| Lojuxta 60 mg - Capsule, hard | Amryt Pharmaceuticals DAC | PLGB 50688/0006 |
| Besremi 250 ug/0.5 ml Solution for injection in pre-filled pen | AOP ORPHAN PHARMACEUTICALS AG | PLGB 21344/0026 |
| Besremi 500 ug/0.5 ml Solution for injection in pre-filled pen | AOP ORPHAN PHARMACEUTICALS AG | PLGB 21344/0027 |
| Clopidogrel Apotex 75 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/2057 |
| Grastofil 30 MU - Solution for injection/infusion | Apotex B.V | PLGB 51315/0001 |
| Grastofil 48 MU - Solution for injection/infusion | Apotex B.V | PLGB 51315/0002 |
| Arixtra Fondaparinux sodium solution for injection 1,5 mg/ 0,3 ml | Mylan Products Ltd | PLGB 46302/0229 |
| Arixtra Fondaparinux sodium solution for injection 10 mg/ 0,8 ml | Mylan Products Ltd | PLGB 46302/0230 |
| Arixtra Fondaparinux sodium solution for injection 2,5 mg/ 0,5 ml | Mylan Products Ltd | PLGB 46302/0231 |
| Arixtra Fondaparinux sodium solution for injection 5 mg/ 0,4 ml | Mylan Products Ltd | PLGB 46302/0232 |
| Arixtra Fondaparinux sodium solution for injection 7,5 mg/ 0,6 ml | Mylan Products Ltd | PLGB 46302/0233 |
| Advagraf 0.5 mg - Prolonged-release capsule, hard | Astellas Pharma Limited | PLGB 00166/0411 |
| Advagraf 1 mg - Prolonged-release capsule, hard | Astellas Pharma Limited | PLGB 00166/0412 |
| Advagraf 3 mg - Prolonged-release capsule, hard | Astellas Pharma Limited | PLGB 00166/0413 |
| Advagraf 5 mg - Prolonged-release capsule, hard | Astellas Pharma Limited | PLGB 00166/0414 |
| Betmiga 25 mg - Prolonged-release tablet | Astellas Pharma Limited | PLGB 00166/0415 |
| Betmiga 50 mg - Prolonged-release tablet | Astellas Pharma Limited | PLGB 00166/0416 |
| Dificlir 200 mg - Film-coated tablet | Tillotts Pharma UK Limited | PLGB 36633/0015 |
| Modigraf 0.2 mg - Granules for oral suspension | Astellas Pharma Limited | PLGB 00166/0418 |
| Modigraf 1 mg - Granules for oral suspension | Astellas Pharma Limited | PLGB 00166/0419 |
| Mycamine 100 mg - Powder for solution for infusion | Astellas Pharma Limited | PLGB 00166/0420 |
| Mycamine 50 mg - Powder for solution for infusion | Astellas Pharma Limited | PLGB 00166/0421 |
| Xtandi 40 mg - Capsule, soft | Astellas Pharma Limited | PLGB 00166/0422 |
| Xtandi 40 mg - Film-coated tablet | Astellas Pharma Limited | PLGB 00166/0423 |
| Xtandi 80 mg - Film-coated tablet | Astellas Pharma Limited | PLGB 00166/0424 |
| Xospata (gilteritinib) 40mg Film-coated tablet | Astellas Pharma Limited | PLGB 00166/0425 |
| Bevespi Aerosphere 7.2 ?g / 5.0?g Pressurised inhalation, suspension | AstraZeneca UK Limited | PLGB 17901/0309 |
| Brilique 60 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0310 |
| Brilique 90 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0311 |
| Brilique 90 mg - Orodispersible tablet | AstraZeneca UK Limited | PLGB 17901/0312 |
| Bydureon 2 mg powder and solvent for prolonged release suspension for injection in pre filled pen | AstraZeneca UK Limited | PLGB 17901/0314 |
| Bydureon 2 mg prolonged-release suspension for injection in pre-filled pen | AstraZeneca UK Limited | PLGB 17901/0315 |
| BYETTA 10 micrograms - Solution for injection | AstraZeneca UK Limited | PLGB 17901/0316 |
| BYETTA 5 micrograms - Solution for injection | AstraZeneca UK Limited | PLGB 17901/0317 |
| Daxas 250 µg - Tablet | AstraZeneca UK Limited | PLGB 17901/0318 |
| Daxas 500 µg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0319 |
| Duaklir Genuair 340 µg + 12 µg - Inhalation powder | AstraZeneca UK Limited | PLGB 17901/0320 |
| Eklira Genuair 322 µg - Inhalation powder, pre-dispensed | AstraZeneca UK Limited | PLGB 17901/0321 |
| Fasenra 30 mg - Solution for injection pre-filled syringe | AstraZeneca UK Limited | PLGB 17901/0322 |
| Faslodex 250 mg/5 ml - Solution for injection | AstraZeneca UK Limited | PLGB 17901/0323 |
| Fluenz Tetra - Nasal spray, suspension | AstraZeneca UK Limited | PLGB 17901/0324 |
| Forxiga 10 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0325 |
| Forxiga 5 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0326 |
| Imfinzi 50 mg/ml - Concentrate for solution for infusion | AstraZeneca UK Limited | PLGB 17901/0327 |
| Iressa 250 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0328 |
| Komboglyze 2.5 mg + 1000 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0329 |
| Komboglyze 2.5 mg + 850 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0330 |
| Lokelma 10 g - Powder for oral suspension | AstraZeneca UK Limited | PLGB 17901/0331 |
| Lokelma 5 g - Powder for oral suspension | AstraZeneca UK Limited | PLGB 17901/0332 |
| Lynparza 100 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0333 |
| Lynparza 150 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0334 |
| Lynparza 50 mg - Capsule, hard | AstraZeneca UK Limited | PLGB 17901/0335 |
| Onglyza 2.5 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0336 |
| Onglyza 5 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0337 |
| Pandemic influenza vaccine H5N1 AstraZeneca Reassortant influenza virus* (live attenuated) of: FFU - Nasal spray, suspension | AstraZeneca UK Limited | PLGB 17901/0338 |
| Qtern 5 mg/10 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0339 |
| TAGRISSO 40 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0340 |
| TAGRISSO 80 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0341 |
| Xigduo 5 mg + 1000 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0342 |
| Xigduo 5 mg + 850 mg - Film-coated tablet | AstraZeneca UK Limited | PLGB 17901/0343 |
| Fasenra 30 mg solution for injection in pre-filled pen | AstraZeneca UK Limited | PLGB 17901/0350 |
| Bondronat 2 mg/2 ml - Concentrate for solution for infusion | Atnahs Pharma UK Limited | PLGB 43252/0019 |
| Bondronat 50 mg - Film-coated tablet | Atnahs Pharma UK Limited | PLGB 43252/0020 |
| Bondronat 6 mg/6 ml - Concentrate for solution for infusion | Atnahs Pharma UK Limited | PLGB 43252/0021 |
| Bonviva 150 mg - Film-coated tablet | Atnahs Pharma UK Limited | PLGB 43252/0022 |
| Bonviva 3 mg/3ml - Solution for injection | Atnahs Pharma UK Limited | PLGB 43252/0023 |
| Rilutek 50 mg - Film-coated tablet | Aventis Pharma Limited | PLGB 04425/0759 |
| Latuda 18.5 mg - Film-coated tablet | Aziende Chimiche Riunite Angelini Francesco S.p.A. | PLGB 17954/0003 |
| Latuda 37 mg - Film-coated tablet | Aziende Chimiche Riunite Angelini Francesco S.p.A. | PLGB 17954/0004 |
| Latuda 74 mg - Film-coated tablet | Aziende Chimiche Riunite Angelini Francesco S.p.A. | PLGB 17954/0005 |
| Cresemba 100 mg - Capsule, hard | Basilea Medical Limited | PLGB 32205/0005 |
| Cresemba 200 mg - Powder for concentrate for solution for infusion | Basilea Medical Limited | PLGB 32205/0006 |
| Relistor 12 mg - Solution for injection in pre-filled syringe | Bausch Health Ireland | PLGB 52637/0003 |
| Relistor 12 mg/0.6 ml - Solution for injection | Bausch Health Ireland | PLGB 52637/0004 |
| Relistor 8 mg - Solution for injection in pre-filled syringe | Bausch Health Ireland | PLGB 52637/0005 |
| Yellox 0.9 mg/ml - Eye drops, solution | Bausch Health Ireland | PLGB 52637/0006 |
| IMVANEX - Suspension for injection | Bavarian Nordic A/S | PLGB 40365/0002 |
| ADYNOVI 1000 IU / 2ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0045 |
| ADYNOVI 1000 IU / 5 ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0046 |
| ADYNOVI 2000 IU - Powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0047 |
| ADYNOVI 250 IU / 2ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0048 |
| ADYNOVI 250 IU / 5 ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0049 |
| ADYNOVI 500 IU / 2 ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0050 |
| ADYNOVI 500 IU / 5 ml powder and solvent for solution for injection | Takeda UK Ltd | PLGB 16189/0051 |
| HyQvia 100 mg/ml - Solution for infusion | Baxalta Innovations GmbH | PLGB 34078/0024 |
| Obizur 500 U - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0025 |
| Rixubis 1000 IU/vial - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0026 |
| Rixubis 2000 IU/vial - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0027 |
| Rixubis 250 IU/vial - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0028 |
| Rixubis 3000 IU/vial - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0029 |
| Rixubis 500 IU/vial - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0030 |
| VEYVONDI 1300 IU - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0032 |
| VEYVONDI 650 IU - Powder and solvent for solution for injection | Baxalta Innovations GmbH | PLGB 34078/0031 |
| Advate 1000 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0039 |
| Advate 1500 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0040 |
| Advate 2000 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0041 |
| Advate 250 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0042 |
| Advate 3000 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0043 |
| Advate 500 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0044 |
| Ceprotin 1000 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0056 |
| Ceprotin 500 IU - Powder and solvent for solution for injection | Takeda UK Ltd. | PLGB 16189/0057 |
| Kiovig 100 mg/ml - Solution for infusion | Takeda UK Ltd | PLGB 16189/0066 |
| Adempas 0.5 mg - Film-coated tablet | Bayer plc | PLGB 00010/0670 |
| Adempas 1 mg - Film-coated tablet | Bayer plc | PLGB 00010/0671 |
| Adempas 1.5 mg - Film-coated tablet | Bayer plc | PLGB 00010/0672 |
| Adempas 2.0 mg - Film-coated tablet | Bayer plc | PLGB 00010/0673 |
| Adempas 2.5 mg - Film-coated tablet | Bayer plc | PLGB 00010/0674 |
| Betaferon 0.25 mg/ml - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0675 |
| Eylea 40 mg/ml solution for injection in pre-filled syringe | Bayer plc | PLGB 00010/0676 |
| Eylea 40 mg/ml solution for injection in a vial | Bayer plc | PLGB 00010/0745 |
| Jivi 1000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0682 |
| Jivi 2000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0683 |
| Jivi 250 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0684 |
| Jivi 3000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0685 |
| Jivi 500 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0686 |
| Kovaltry 1000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0692 |
| Kovaltry 2000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0693 |
| Kovaltry 250 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0694 |
| Kovaltry 3000 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0695 |
| Kovaltry 500 IU - Powder and solvent for solution for injection | Bayer plc | PLGB 00010/0696 |
| Levitra 10 mg - Film-coated tablet | Bayer plc | PLGB 00010/0697 |
| Levitra 10 mg - Orodispersible tablet | Bayer plc | PLGB 00010/0698 |
| Levitra 20 mg - Film-coated tablet | Bayer plc | PLGB 00010/0699 |
| Levitra 5 mg - Film-coated tablet | Bayer plc | PLGB 00010/0700 |
| Nexavar 200 mg - Film-coated tablet | Bayer plc | PLGB 00010/0701 |
| Stivarga 40 mg - Film-coated tablet | Bayer plc | PLGB 00010/0702 |
| Ventavis 10 µg/ml - Nebuliser solution | Bayer plc | PLGB 00010/0703 |
| Ventavis 20 µg/ml - Nebuliser solution | Bayer plc | PLGB 00010/0704 |
| Xarelto 10 mg - Film-coated tablet | Bayer plc | PLGB 00010/0705 |
| Xarelto 15 mg - Film-coated tablet | Bayer plc | PLGB 00010/0706 |
| Xarelto 15 mg + 20 mg - Film-coated tablet | Bayer plc | PLGB 00010/0707 |
| Xarelto 2.5 mg - Film-coated tablet | Bayer plc | PLGB 00010/0708 |
| Xarelto 20 mg - Film-coated tablet | Bayer plc | PLGB 00010/0709 |
| Xofigo 1100 kBq/mL - Solution for injection | Bayer plc | PLGB 00010/0710 |
| Vitrakvi 20 mg/mL oral solution | Bayer plc | PLGB 00010/0741 |
| Vitrakvi 25 mg hard capsules | Bayer plc | PLGB 00010/0742 |
| Vitrakvi 100 mg hard capsules | Bayer plc | PLGB 00010/0743 |
| elmiron 100 mg - Capsule, hard | bene-Arzneimittel GmbH | PLGB 12404/0001 |
| Ongentys 25 mg - Capsule, hard | Bial - Portela & Cª, S.A. | PLGB 21566/0003 |
| Ongentys 50 mg - Capsule, hard | Bial - Portela & Cª, S.A. | PLGB 21566/0004 |
| Zebinix 200 mg - Tablet | Bial - Portela & Cª, S.A. | PLGB 21566/0005 |
| Zebinix 400 mg - Tablet | Bial - Portela & Cª, S.A. | PLGB 21566/0006 |
| Zebinix 50 mg/ml - Oral suspension | Bial - Portela & Cª, S.A. | PLGB 21566/0007 |
| Zebinix 600 mg - Tablet | Bial - Portela & Cª, S.A. | PLGB 21566/0008 |
| Zebinix 800 mg - Tablet | Bial - Portela & Cª, S.A. | PLGB 21566/0009 |
| Coagadex 250 IU - Powder and solvent for solution for injection | Bio Products Laboratory Limited | PLGB 08801/0059 |
| Coagadex 500 IU - Powder and solvent for solution for injection | Bio Products Laboratory Limited | PLGB 08801/0060 |
| Diacomit 250 mg - Capsule, hard | BIOCODEX | PLGB 23211/0005 |
| Diacomit 250 mg - Powder for oral suspension | BIOCODEX | PLGB 23211/0006 |
| Diacomit 500 mg - Capsule, hard | BIOCODEX | PLGB 23211/0007 |
| Diacomit 500 mg - Powder for oral suspension | BIOCODEX | PLGB 23211/0008 |
| Ameluz 78 mg/g - Gel | Biofrontera Bioscience GmbH | PLGB 34942/0002 |
| Avonex 30 µg/0.5 ml (6 million IU) - Solution for injection | BIOGEN NETHERLANDS BV | PLGB 22407/0014 |
| Fampyra 10 mg - Prolonged-release tablet | BIOGEN NETHERLANDS BV | PLGB 22407/0015 |
| Plegridy 125 µg - Solution for injection in a pre filled pen | BIOGEN NETHERLANDS BV | PLGB 22407/0019 |
| Plegridy 63 µg; Solution for injection in a pre filled pen | BIOGEN NETHERLANDS BV | PLGB 22407/0016 |
| Plegridy 94 µg; Solution for injection in a pre filled pen | BIOGEN NETHERLANDS BV | PLGB 22407/0017 |
| Spinraza 12 mg - Solution for injection | BIOGEN NETHERLANDS BV | PLGB 22407/0018 |
| TECFIDERA 120 mg - Gastro-resistant capsule, hard | BIOGEN NETHERLANDS BV | PLGB 22407/0012 |
| TECFIDERA 240 mg - Gastro-resistant capsule, hard | BIOGEN NETHERLANDS BV | PLGB 22407/0013 |
| Tysabri 300 mg - Concentrate for solution for infusion | BIOGEN NETHERLANDS BV | PLGB 22407/0010 |
| Brineura 150 mg - Solution for infusion | BioMarin International Limited | PLGB 45814/0001 |
| Kuvan 100 mg - Powder for oral solution | BioMarin International Limited | PLGB 45814/0003 |
| Kuvan 100 mg - Soluble tablet | BioMarin International Limited | PLGB 45814/0004 |
| Firdapse 10 mg tablet | SERB SA | PLGB 43956/0005 |
| Kuvan 500 mg - Powder for oral solution | BioMarin International Limited | PLGB 45814/0005 |
| Naglazyme 1 mg/ml - Concentrate for solution for infusion | BioMarin International Limited | PLGB 45814/0006 |
| Vimizim 1 mg/ml - Concentrate for solution for infusion | BioMarin International Limited | PLGB 45814/0007 |
| Wakix 18 mg - Film-coated tablet | BIOPROJET PHARMA | PLGB 26351/0005 |
| Wakix 4.5 mg - Film-coated tablet | BIOPROJET PHARMA | PLGB 26351/0006 |
| Zutectra 500 IU - Solution for injection | Biotest Pharma GmbH | PLGB 04500/0014 |
| Axumin 1600 MBq/ml - Solution for injection | Blue Earth Diagnostics Ltd | PLGB 44578/0001 |
| Axumin 3200 MBq/ml - Solution for injection | Blue Earth Diagnostics Ltd | PLGB 44578/0002 |
| Zynteglo 1.2-20 x 106 cells/mL | bluebird bio (Netherlands) B.V. | PLGB 51370/0001 |
| Aptivus 250 mg - Capsule, soft | Boehringer Ingelheim Limited | PLGB 14598/0185 |
| Giotrif 20 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0186 |
| Giotrif 30 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0187 |
| Giotrif 40 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0188 |
| Giotrif 50 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0189 |
| Glyxambi 10 mg + 5 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0190 |
| Glyxambi 25 mg + 5 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0191 |
| Jardiance 10 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0192 |
| Jardiance 25 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0193 |
| Jentadueto 2.5 mg + 1000 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0194 |
| Jentadueto 2.5 mg + 850 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0195 |
| Metalyse 10000 Units - Powder and solvent for solution for injection | Boehringer Ingelheim GMBH | PLGB 14598/0196 |
| Metalyse 8000 Units - Powder and solvent for solution for injection | Boehringer Ingelheim GMBH | PLGB 14598/0197 |
| Micardis 20 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0198 |
| Micardis 40 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0199 |
| Micardis 80 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0200 |
| Micardisplus 40 mg + 12.5 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0201 |
| Micardisplus 80 mg + 12.5 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0202 |
| Micardisplus 80 mg + 25 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0203 |
| Mirapexin 0.088 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0204 |
| Mirapexin 0.18 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0205 |
| Mirapexin 0.26 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0206 |
| Mirapexin 0.35 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0207 |
| Mirapexin 0.52 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0208 |
| Mirapexin 0.7 mg - Tablet | Boehringer Ingelheim GMBH | PLGB 14598/0209 |
| Mirapexin 1.05 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0210 |
| Mirapexin 1.57 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0211 |
| Mirapexin 2.1 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0212 |
| Mirapexin 2.62 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0213 |
| Mirapexin 3.15 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0214 |
| OFEV 100 mg - Capsule, soft | Boehringer Ingelheim GMBH | PLGB 14598/0215 |
| OFEV 150 mg - Capsule, soft | Boehringer Ingelheim GMBH | PLGB 14598/0216 |
| Pradaxa 110 mg - Capsule, hard | Boehringer Ingelheim GMBH | PLGB 14598/0217 |
| Pradaxa 150 mg - Capsule, hard | Boehringer Ingelheim GMBH | PLGB 14598/0218 |
| Pradaxa 75 mg - Capsule, hard | Boehringer Ingelheim GMBH | PLGB 14598/0219 |
| Praxbind 2.5 g/50 mL - Solution for injection/infusion | Boehringer Ingelheim GMBH | PLGB 14598/0220 |
| Synjardy 12.5 mg + 1000 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0221 |
| Synjardy 12.5 mg + 850 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0222 |
| Synjardy 5 mg + 1000 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0223 |
| Synjardy 5 mg + 850 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0224 |
| Trajenta 5 mg - Film-coated tablet | Boehringer Ingelheim GMBH | PLGB 14598/0225 |
| Vargatef 100 mg - Capsule, soft | Boehringer Ingelheim GMBH | PLGB 14598/0226 |
| Vargatef 150 mg - Capsule, soft | Boehringer Ingelheim GMBH | PLGB 14598/0227 |
| Viramune 100 mg - Prolonged-release tablet | Boehringer Ingelheim GMBH | PLGB 14598/0228 |
| Viramune 50 mg/5 ml - Oral suspension | Boehringer Ingelheim GMBH | PLGB 14598/0229 |
| SonoVue 8 µl/ml - Powder and solvent for dispersion for injection | Bracco UK Limited | PLGB 18920/0025 |
| Eliquis 2.5 mg - Film-coated tablet | Bristol-Myers Squibb EEIG | PLGB 54213/0001 |
| Eliquis 5 mg - Film-coated tablet | Bristol-Myers Squibb EEIG | PLGB 54213/0002 |
| Baraclude 0.05 mg/ml - Oral solution | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0128 |
| Baraclude 0.5 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0126 |
| Baraclude 1 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0127 |
| Empliciti 300 mg - Powder for concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0129 |
| Empliciti 400 mg - Powder for concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0130 |
| EVOTAZ 300 mg + 150 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0131 |
| Nulojix 250 mg - Powder for concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0132 |
| OPDIVO 10 mg/ml - Concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0133 |
| Orencia 125 mg - Solution for injection | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0134 |
| Orencia 250 mg - Powder for concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0135 |
| Orencia 50 mg - solution for injection | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0136 |
| Orencia 87.5 mg - solution for injection | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0137 |
| Orencia 125mg - solution for injection in pre filled pen | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0174 |
| Reyataz 150 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0138 |
| Reyataz 200 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0139 |
| Reyataz 300 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0140 |
| Sprycel 10 mg/ml - Powder for oral suspension | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0141 |
| Sprycel 100 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0142 |
| Sprycel 140 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0143 |
| Sprycel 20 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0144 |
| Sprycel 50 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0145 |
| Sprycel 80 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0146 |
| Sustiva 100 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0147 |
| Sustiva 200 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0148 |
| Sustiva 50 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0149 |
| Sustiva 600 mg - Film-coated tablet | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0150 |
| Yervoy 5 mg/ml - Concentrate for solution for infusion | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0151 |
| Buvidal 8 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0001 |
| Buvidal 16 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0009 |
| Buvidal 24 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0003 |
| Buvidal 32 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0004 |
| Buvidal 64 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0005 |
| Buvidal 96 mg prolonged-release solution for injection | Camurus AB | PLGB 42800/0006 |
| Buvidal 128 mg prolonged-release solution for injection | Camurus AB | PLGB 42807/0007 |
| Vidaza 25 mg/ml - Powder for suspension for injection | Celgene Europe BV | PLGB 50412/0016 |
| Azacitidine Celgene 25 mg/ml Powder for suspension for injection | Celgene Europe BV | PLGB 50412/0017 |
| Zevalin 1.6 mg/ml - Kit for radiopharmaceutical preparation | Ceft Biopharma s.r.o. | PLGB 53745/0001 |
| Abraxane 5 mg/ml - Powder for suspension for infusion | Celgene Europe BV | PLGB 50412/0001 |
| Imnovid 1 mg - Capsule, hard | Celgene Europe BV | PLGB 50412/0002 |
| Imnovid 2 mg - Capsule, hard | Celgene Europe BV | PLGB 50412/0003 |
| Imnovid 3 mg - Capsule, hard | Celgene Europe BV | PLGB 50412/0004 |
| Imnovid 4 mg - Capsule, hard | Celgene Europe BV | PLGB 50412/0005 |
| Otezla 10 mg + 20 mg + 30 mg - Film-coated tablet | Amgen Limited | PLGB 13832/0047 |
| Otezla 30 mg - Film-coated tablet | Amgen Limited | PLGB 13832/0048 |
| Revlimid 10 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0116 |
| Revlimid 15 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0117 |
| Revlimid 2.5 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0118 |
| Revlimid 20 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0119 |
| Revlimid 25 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0120 |
| Revlimid 5 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0121 |
| Revlimid 7.5 mg - Capsule, hard | Bristol-Myers Squibb Pharma EEIG | PLGB 15105/0122 |
| Thalidomide Celgene 50 mg - Capsule, hard | Celgene Europe BV | PLGB 50412/0015 |
| Herzuma 150 mg - Powder for concentrate for solution for infusion | Celltrion Healthcare Hungary Kft. | PLGB 43494/0013 |
| Herzuma 420 mg - Powder for concentrate for solution for infusion | Celltrion Healthcare Hungary Kft. | PLGB 43494/0014 |
| Remsima 100 mg - Powder for concentrate for solution for infusion | Celltrion Healthcare Hungary Kft. | PLGB 43494/0015 |
| Truxima 100 mg - Concentrate for solution for infusion | Celltrion Healthcare Hungary Kft. | PLGB 43494/0019 |
| Truxima 500 mg - Concentrate for solution for infusion | Celltrion Healthcare Hungary Kft. | PLGB 43494/0020 |
| Xenical 120 mg - Capsule, hard | CHEPLAPHARM Arzneimittel GmbH | PLGB 27041/0014 |
| Visudyne 15 mg Powder for solution for infusion | CHEPLAPHARM Arzneimittel GmbH | PLGB 27041/0028 |
| Ferriprox 100 mg/ml Oral solution | Chiesi Limited | PLGB 08829/0196 |
| Ferriprox 1000 mg Film-coated tablet | Chiesi Limited | PLGB 08829/0197 |
| Ferriprox 500 mg Film-coated tablet | Chiesi Limited | PLGB 08829/0198 |
| Envarsus 0.75 mg - Prolonged-release tablet | Chiesi Limited | PLGB 08829/0183 |
| Envarsus 1 mg - Prolonged-release tablet | Chiesi Limited | PLGB 08829/0184 |
| Envarsus 4 mg - Prolonged-release tablet | Chiesi Limited | PLGB 08829/0185 |
| Holoclar 79,000 – 316,000 cells/cm² living tissue equivalent | Holostem Terapie Avanzate s.r.l | PLGB 53298/0001 |
| Kengrexal 50 mg - Powder for concentrate for solution for injection/ infusion | Chiesi Limited | PLGB 08829/0187 |
| Lamzede 10 mg - Powder for infusion | Chiesi Limited | PLGB 08829/0188 |
| SCENESSE 16 mg - Implant | CLINUVEL (UK) LTD | PLGB 30619/0002 |
| Peyona 20 mg / ml - Solution for infusion and oral solution | Chiesi Limited | PLGB 08829/0189 |
| Spherox 10–70 spheroids/cm² - Implantation suspension | CO.DON AG | PLGB 50857/0003 |
| Procysbi 25 mg - Gastro-resistant capsule, hard | Chiesi Limited | PLGB 08829/0190 |
| Procysbi 75 mg - Gastro-resistant capsule, hard | Chiesi Limited | PLGB 08829/0191 |
| Quinsair 240 mg - Nebuliser solution | Chiesi Limited | PLGB 08829/0192 |
| Trimbow 87 µg + 5 µg + 9 µg - Pressurised inhalation, solution | Chiesi Limited | PLGB 08829/0193 |
| Pelmeg 6 mg Solution for injection | Napp Pharmaceuticals Limited | PLGB 16950/0388 |
| Quadramet 2 to 4 GBq per vial at calibration date - Solution for injection | CIS BIO International | PLGB 11876/0024 |
| Scintimun 1 mg - Kit for radiopharmaceutical preparation | CIS BIO International | PLGB 11876/0025 |
| Ytracis 1.850 GBq/ml - Radiopharmaceutical precursor, solution | CIS BIO International | PLGB 11876/0026 |
| Striascan 74 MBq/mL solution for injection | CIS BIO International | PLGB 11876/0027 |
| Savene 20 mg/ml - Powder and solvent for concentrate for solution for infusion | Clinigen Healthcare Ltd | PLGB 31644/0005 |
| Brinavess 20 mg/ml - Concentrate for solution for infusion | Correvio | PLGB 48998/0003 |
| Rubraca 200 mg - Film-coated tablet | Clovis Oncology Ireland Limited | PLGB 50731/0001 |
| Rubraca 250 mg - Film-coated tablet | Clovis Oncology Ireland Limited | PLGB 50731/0002 |
| Rubraca 300 mg - Film-coated tablet | Clovis Oncology Ireland Limited | PLGB 50731/0003 |
| Afstyla 1000 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0133 |
| Afstyla 1500 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0134 |
| Afstyla 2000 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0135 |
| Afstyla 250 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0136 |
| Afstyla 2500 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0137 |
| Afstyla 3000 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0138 |
| Afstyla 500 IU - Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0139 |
| Hizentra 200 mg/ml solution for subcutaneous injection | CSL Behring Marburg | PLGB 15036/0140 |
| Hizentra 200 mg/ml solution for subcutaneous injection in pre-filled syringe | CSL Behring Marburg | PLGB 15036/0156 |
| IDELVION 1000 IU - Powder and solvent for solution for injection | CSL Behring Marburg | PLGB 15036/0141 |
| IDELVION 2000 IU - Powder and solvent for solution for injection | CSL Behring Marburg | PLGB 15036/0142 |
| IDELVION 250 IU - Powder and solvent for solution for injection | CSL Behring Marburg | PLGB 15036/0143 |
| IDELVION 500 IU - Powder and solvent for solution for injection | CSL Behring Marburg | PLGB 15036/0144 |
| IDELVION 3500 IU - Powder and solvent for solution for injection | CSL Behring Marburg | PLGB 15036/0155 |
| Privigen 100 mg/ml - Solution for infusion | CSL Behring Marburg | PLGB 15036/0145 |
| Respreeza 1000 mg - Powder and solvent for solution for infusion | CSL Behring Marburg | PLGB 15036/0146 |
| Respreeza 4000 mg - Powder and solvent for solution for infusion | CSL Behring Marburg | PLGB 15036/0147 |
| Respreeza 5000 mg - Powder and solvent for solution for infusion | CSL Behring Marburg | PLGB 15036/0148 |
| Voncento 1000 IU/ 2400 IU Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0149 |
| Voncento 250 IU/ 600 IU Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0150 |
| Voncento 500 IU/1200 IU 5ml Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0158 |
| Voncento 500 IU /1200 IU 10ml Powder and solvent for solution for injection/infusion | CSL Behring Marburg | PLGB 15036/0151 |
| Nityr 10 mg - Tablet | Cycle Pharmaceuticals Limited | PLGB 45886/0001 |
| Efient 10 mg - Film-coated tablet | Daiichi Sankyo UK Ltd. | PLGB 08265/0037 |
| Efient 5 mg - Film-coated tablet | Daiichi Sankyo UK Ltd. | PLGB 08265/0038 |
| Lixiana 15 mg - Film-coated tablet | Daiichi Sankyo UK Ltd. | PLGB 08265/0040 |
| Lixiana 30 mg - Film-coated tablet | Daiichi Sankyo UK Ltd. | PLGB 08265/0041 |
| Lixiana 60 mg - Film-coated tablet | Daiichi Sankyo UK Ltd. | PLGB 08265/0042 |
| Yttriga 0.1-300 GB - Radiopharmaceutical precursor, solution | Eckert & Ziegler Radiopharma GmbH | PLGB 46734/0002 |
| Alkindi 0.5 mg – Granules in capsules for opening | Diurnal Europe B.V | PLGB 50616/0007 |
| Alkindi 1.0 mg – Granules in capsules for opening | Diurnal Europe B.V | PLGB 50616/0008 |
| Alkindi 2.0 mg – Granules in capsules for opening | Diurnal Europe B.V | PLGB 50616/0009 |
| Alkindi 5.0 mg – Granules in capsules for opening | Diurnal Europe B.V | PLGB 50616/0010 |
| Abasaglar 100 Units/ml - Solution for injection in a cartridge | Eli Lilly Nederland B.V. | PLGB 14895/0226 |
| ABASAGLAR 100 units/mL KwikPen solution for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0227 |
| Kisplyx 10 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0006 |
| Kisplyx 4 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0007 |
| Lenvima 10 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0008 |
| Lenvima 4 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0009 |
| Fycompa 0.5 mg/ml - Oral suspension | Eisai Europe Limited | PLGB 33967/0010 |
| Fycompa 10 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0011 |
| Fycompa 12 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0012 |
| Fycompa 2 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0013 |
| Fycompa 4 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0014 |
| Fycompa 6 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0015 |
| Fycompa 8 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0016 |
| Halaven 0.44 mg/ml - Solution for injection | Eisai Europe Limited | PLGB 33967/0017 |
| Inovelon 100 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0018 |
| Inovelon 200 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0019 |
| Inovelon 40 mg/ml - Oral suspension | Eisai Europe Limited | PLGB 33967/0020 |
| Inovelon 400 mg - Film-coated tablet | Eisai Europe Limited | PLGB 33967/0021 |
| Targretin 75 mg - Capsule, soft | Eisai Europe Limited | PLGB 33967/0022 |
| Zonegran 100 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0023 |
| Zonegran 25 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0024 |
| Zonegran 50 mg - Capsule, hard | Eisai Europe Limited | PLGB 33967/0025 |
| Adcirca film-caoted tablets 20mg | Eli Lilly Nederland B.V. | PLGB 14895/0229 |
| Alimta 100 mg - Powder for concentrate for solution for infusion | Eli Lilly Nederland B.V. | PLGB 14895/0230 |
| Alimta 500 mg - Powder for concentrate for solution for infusion | Eli Lilly Nederland B.V. | PLGB 14895/0231 |
| Amyvid 1900 MBq/ml - Solution for injection | Eli Lilly Nederland B.V. | PLGB 14895/0233 |
| Amyvid 800 MBq/ml - Solution for injection | Eli Lilly Nederland B.V. | PLGB 14895/0232 |
| Cialis 2.5 mg - Film- coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0235 |
| Cialis 5 mg - Film- coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0236 |
| Cialis 10 mg - Film- coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0237 |
| Cialis 20 mg - Film- coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0238 |
| Cymbalta 30 mg - Gastro-resistant capsule, hard | Eli Lilly Nederland B.V. | PLGB 14895/0239 |
| Cymbalta 60 mg - Gastro-resistant capsule, hard | Eli Lilly Nederland B.V. | PLGB 14895/0240 |
| Cyramza 10 mg/ml - Concentrate for solution for infusion | Eli Lilly Nederland B.V. | PLGB 14895/0241 |
| Emgality 120 mg - Solution for injection pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0242 |
| Emgality 120 mg - Solution for injection pre-filled syringe | Eli Lilly Nederland B.V. | PLGB 14895/0286 |
| Forsteo 20 µg/80 µl - Solution for injection | Eli Lilly Nederland B.V. | PLGB 14895/0243 |
| Humalog 100 units/ml solution for injection in vial | Eli Lilly Nederland B.V. | PLGB 14895/0244 |
| Humalog 100 units/ml solution for injection in cartridge | Eli Lilly Nederland B.V. | PLGB 14895/0245 |
| Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0246 |
| Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0247 |
| Humalog 200 units/ml KwikPen solution for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0248 |
| Humalog Mix25 100 units/ml suspension for injection in vial | Eli Lilly Nederland B.V. | PLGB 14895/0249 |
| Humalog Mix25 100 units/ml suspension for injection in cartridge | Eli Lilly Nederland B.V. | PLGB 14895/0250 |
| Humalog Mix25 100 units/ml KwikPen suspension for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0251 |
| Humalog Mix50 100 units/ml suspension for injection in cartridge | Eli Lilly Nederland B.V. | PLGB 14895/0252 |
| Humalog Mix50 100 units/ml KwikPen suspension for injection in a pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0253 |
| Olumiant 2 mg - Film-coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0255 |
| Olumiant 4 mg - Film-coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0256 |
| Taltz 80 mg - Solution for injection pre-filled SYRINGE | Eli Lilly Nederland B.V. | PLGB 14895/0258 |
| Taltz 80 mg - Solution for injection pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0257 |
| Trulicity 0.75 mg - Solution for injection pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0259 |
| Trulicity 0.75 mg - Solution for injection syringe | Eli Lilly Nederland B.V. | PLGB 14895/0287 |
| Trulicity 1.5 mg - Solution for injection pre-filled pen | Eli Lilly Nederland B.V. | PLGB 14895/0260 |
| Trulicity 1.5 mg - Solution for injection syringe | Eli Lilly Nederland B.V. | PLGB 14895/0288 |
| Verzenios 50 mg - Film-coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0263 |
| Verzenios 100 mg - Film-coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0264 |
| Verzenios 150 mg - Film-coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0265 |
| Yentreve 20 mg - Gastro-resistant capsule, hard | Eli Lilly Nederland B.V. | PLGB 14895/0266 |
| Yentreve 40 mg - Gastro-resistant capsule, hard | Eli Lilly Nederland B.V. | PLGB 14895/0267 |
| Zypadhera 210 mg - Powder and solvent for prolonged-release suspension for injection | Eli Lilly Nederland B.V. | PLGB 14895/0268 |
| Zypadhera 300 mg - Powder and solvent for prolonged-release suspension for injection | Eli Lilly Nederland B.V. | PLGB 14895/0269 |
| Zypadhera 405 mg - Powder and solvent for prolonged-release suspension for injection | Eli Lilly Nederland B.V. | PLGB 14895/0270 |
| Zyprexa 10 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0273 |
| Zyprexa 15 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0275 |
| Zyprexa 2.5 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0271 |
| Zyprexa 20 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0276 |
| Zyprexa 5 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0272 |
| Zyprexa 7.5 mg - Coated tablet | Eli Lilly Nederland B.V. | PLGB 14895/0274 |
| Zyprexa Velotab 5 mg - Orodispersible tablet | Eli Lilly Nederland B.V. | PLGB 14895/0277 |
| Zyprexa Velotab 10 mg - Orodispersible tablet | Eli Lilly Nederland B.V. | PLGB 14895/0278 |
| Zyprexa Velotab 15 mg - Orodispersible tablet | Eli Lilly Nederland B.V. | PLGB 14895/0279 |
| Zyprexa Velotab 20 mg - Orodispersible tablet | Eli Lilly Nederland B.V. | PLGB 14895/0280 |
| Intrarosa 6.5 mg - Pessary | Endoceutics S.A | PLGB 51839/0002 |
| Granupas 4 g - Gastro-resistant granules | Eurocept International B.V. | PLGB 35068/0003 |
| Pheburane 483 mg/g - Granules | Eurocept International B.V. | PLGB 35068/0004 |
| Ucedane 200 mg - Dispersible tablet | Eurocept International B.V. | PLGB 35068/0005 |
| Fotivda 1340 µg - Capsule, hard | EUSA Pharma (UK) Limited | PLGB 44185/0003 |
| Fotivda 890 µg - Capsule, hard | EUSA Pharma (UK) Limited | PLGB 44185/0004 |
| Qarziba 4.5 mg/ml - Concentrate for solution for infusion | EUSA Pharma (UK) Limited | PLGB 44185/0005 |
| SYLVANT 100 mg - Powder for concentrate for solution for infusion | EUSA Pharma (UK) Limited | PLGB 44185/0006 |
| SYLVANT 400 mg - Powder for concentrate for solution for infusion | EUSA Pharma (UK) Limited | PLGB 44185/0007 |
| Nuceiva 100 U Powder for solution for injection | EVOLUS | PLGB 51161/0001 |
| Adasuve 4.5 mg - Inhalation powder, pre-dispensed | Ferrer Internacional s.a. | PLGB 27849/0010 |
| Adasuve 9.1 mg - Inhalation powder, pre-dispensed | Ferrer Internacional s.a. | PLGB 27849/0011 |
| Firmagon 120 mg - Powder and solvent for solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0128 |
| Firmagon 80 mg - Powder and solvent for solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0129 |
| Rekovelle 12 µg/0.36 ml - Solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0130 |
| Rekovelle 36 µg/1.08 ml - Solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0131 |
| Rekovelle 72 µg/2.16 ml - Solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0132 |
| Rekovelle solution for injection in prefilled pen, 12mcg/0.36ml | Ferring Pharmaceuticals Limited | PLGB 03194/0133 |
| Rekovelle solution for injection in prefilled pen, 36mcg/1.08ml | Ferring Pharmaceuticals Limited | PLGB 03194/0134 |
| Rekovelle solution for injection in prefilled pen, 72mcg/2.16ml | Ferring Pharmaceuticals Limited | PLGB 03194/0135 |
| Tractocile 37.5 mg/5 ml - Concentrate for solution for infusion | Ferring Pharmaceuticals Limited | PLGB 03194/0136 |
| Tractocile 6.75 mg/0.9 ml - Solution for injection | Ferring Pharmaceuticals Limited | PLGB 03194/0137 |
| Dzuveo 30 ?g - Sublingual tablet | FGK Representative Service GmbH | PLGB 27682/0005 |
| Mirvaso 3 mg/g - Gel | Galderma (UK)Ltd | PLGB 10590/0072 |
| Optison - Dispersion for injection | GE Healthcare AS | PLGB 00637/0068 |
| Rapiscan 400 µg - Solution for injection | GE Healthcare AS | PLGB 00637/0069 |
| Idacio Solution for Injection 40mg/0.8ml vial | Fresenius Kabi Limited | PLGB 08828/0320 |
| Idacio solution for injection 40mg prefilled syringe | Fresenius Kabi Limited | PLGB 08828/0321 |
| Idacio solution for injection 40mg prefilled pen | Fresenius Kabi Limited | PLGB 08828/0322 |
| Busulfan Fresenius Kabi 6 mg/ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0323 |
| Docetaxel Kabi 120 mg/6 ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0324 |
| Docetaxel Kabi 160 mg/8 ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0324 |
| Docetaxel Kabi 180 mg/9 ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0324 |
| Docetaxel Kabi 20 mg/1 ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0324 |
| Docetaxel Kabi 80 mg/4 ml - Concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0324 |
| Bortezomib Fresenius Kabi 2.5 mg - Powder for solution for injection | Fresenius Kabi Limited | PLGB 08828/0330 |
| Bortezomib Fresenius Kabi 1 mg - Powder for solution for injection | Fresenius Kabi Limited | PLGB 08828/0330 |
| Pemetrexed Fresenius Kabi 100 mg - Powder for concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0325 |
| Pemetrexed Fresenius Kabi 500 mg - Powder for concentrate for solution for infusion | Fresenius Kabi Limited | PLGB 08828/0326 |
| BORTEZOMIB FRESENIUS KABI 3.5mg powder for solution for injection | Fresenius Kabi Limited | PLGB 08828/0330 |
| Pemetrexed 25mg/ml concentrate for solution for infusion line extension | Fresenius Kabi Limited | PLGB 08828/0327 |
| DaTSCAN 74 MBq/ml - Solution for injection | GE Healthcare Ltd | PLGB 00221/0387 |
| VIZAMYL 400 MBq/mL - Solution for injection | GE Healthcare Ltd | PLGB 00221/0388 |
| Bemfola 150 IU/0.25 ml - Solution for injection | Gedeon Richter PLC | PLGB 04854/0167 |
| Bemfola 225 IU/0.375 ml - Solution for injection | Gedeon Richter PLC | PLGB 04854/0168 |
| Bemfola 300 IU/0.50 ml - Solution for injection | Gedeon Richter PLC | PLGB 04854/0169 |
| Bemfola 450 IU/0.75 ml - Solution for injection | Gedeon Richter PLC | PLGB 04854/0170 |
| Bemfola 75 IU/0.125 ml - Solution for injection | Gedeon Richter PLC | PLGB 04854/0171 |
| Esmya 5 mg - Tablet | Gedeon Richter PLC | PLGB 04854/0172 |
| Reagila 1.5 mg - Capsule, hard | Gedeon Richter PLC | PLGB 04854/0173 |
| Reagila 3 mg - Capsule, hard | Gedeon Richter PLC | PLGB 04854/0174 |
| Reagila 4.5 mg - Capsule, hard | Gedeon Richter PLC | PLGB 04854/0175 |
| Reagila 6 mg - Capsule, hard | Gedeon Richter PLC | PLGB 04854/0176 |
| Terrosa 20 µg/80 µl - Solution for injection | Gedeon Richter PLC | PLGB 04854/0177 |
| Ulipristal Acetate Gedeon Richter 5 mg - Tablet | Gedeon Richter PLC | PLGB 04854/0178 |
| Miglustat Gen.Orph 100 mg - Capsule, hard | Gen.Orph | PLGB 47541/0003 |
| Olanzapine Glenmark 10 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0302 |
| Olanzapine Glenmark 15 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0303 |
| Memantine Mylan 10 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1943 |
| Memantine Mylan 20 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1944 |
| Olanzapine Mylan 10 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1945 |
| Olanzapine Mylan 15 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1946 |
| Olanzapine Mylan 2.5 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1947 |
| Olanzapine Mylan 20 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1948 |
| Olanzapine Mylan 5 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1949 |
| Olanzapine Mylan 7.5 mg - Film-coated tablet | Generics UK Limited | PLGB 04569/1950 |
| Pregabalin Mylan 100 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1951 |
| Pregabalin Mylan 150 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1952 |
| Pregabalin Mylan 200 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1953 |
| Pregabalin Mylan 225 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1954 |
| Pregabalin Mylan 25 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1955 |
| Pregabalin Mylan 300 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1956 |
| Pregabalin Mylan 50 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1957 |
| Pregabalin Mylan 75 mg - Capsule, hard | Generics UK Limited | PLGB 04569/1958 |
| Ribavrin Mylan 200mg Hard capsule | Generics UK Limited | PLGB 04569/1967 |
| Olanzapine Glenmark 2.5 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0304 |
| Defitelio 80 mg/ml -concentrate for Solution for infusion | Jazz Pharmaceuticals UK Limited | PLGB 31626/0005 |
| Aldurazyme 100 U/ml - Concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0760 |
| Caprelsa 100 mg - Film-coated tablet | Aventis Pharma Limited | PLGB 04425/0761 |
| Caprelsa 300 mg - Film-coated tablet | Aventis Pharma Limited | PLGB 04425/0762 |
| Cerdelga 84 mg - Capsule, hard | Aventis Pharma Limited | PLGB 04425/0763 |
| Cerezyme 400 U - Powder for concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0764 |
| Cholestagel 625 mg - Film-coated tablet | Neon healthcare Limited | PLGB 45043/0064 |
| Evoltra 1 mg/ml - Concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0766 |
| Fabrazyme 35 mg - Powder for concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0767 |
| Fabrazyme 5 mg - Powder for concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0768 |
| Mozobil 20 mg/ml - Solution for injection | Aventis Pharma Limited | PLGB 04425/0769 |
| Myozyme 50 mg - Powder for concentrate for solution for infusion | Aventis Pharma Limited | PLGB 04425/0770 |
| Renagel 800 mg - Film-coated tablet | Aventis Pharma Limited | PLGB 04425/0772 |
| Renvela 0.8 g - Powder for oral suspension | Aventis Pharma Limited | PLGB 04425/0773 |
| Renvela 2.4 g - Powder for oral suspension | Aventis Pharma Limited | PLGB 04425/0784 |
| Renvela 800 mg - Film-coated tablet | Aventis Pharma Limited | PLGB 04425/0785 |
| Thyrogen 0.9 mg - Powder for solution for injection | Aventis Pharma Limited | PLGB 04425/0786 |
| Biktarvy 50 mg/200 mg/25 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0008 |
| Cayston 75 mg Powder and solvent for nebuliser solution | GILEAD SCIENCES LIMITED | PLGB 11972/0009 |
| Descovy 200 mg + 10 mg - Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0010 |
| Descovy 200 mg + 25 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0011 |
| Emtriva 10 mg/ml - Oral solution | GILEAD SCIENCES LIMITED | PLGB 11972/0012 |
| Emtriva 200 mg Capsule, hard | GILEAD SCIENCES LIMITED | PLGB 11972/0013 |
| Epclusa 400 mg + 100 mg - Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0014 |
| Eviplera 200 mg + 25 mg + 245 mg - Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0015 |
| Genvoya 150 mg + 150 mg + 200 mg + 10 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0016 |
| Harvoni 90 mg + 400 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0017 |
| Hepsera 10 mg Tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0018 |
| Odefsey 200 mg + 25 mg + 25 mg - Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0019 |
| Sovaldi 400 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0020 |
| Stribild 150 mg + 150 mg + 200 mg + 245 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0021 |
| Truvada 200 mg + 245 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0022 |
| Tybost 150 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0023 |
| Vemlidy 25 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0024 |
| Viread 123 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0025 |
| Viread 163 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0026 |
| Viread 204 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0027 |
| Viread 245 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0028 |
| Viread 33 mg/g - Granules | GILEAD SCIENCES LIMITED | PLGB 11972/0029 |
| Vosevi 400 mg/100 mg/100 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0030 |
| Zydelig 100 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0031 |
| Zydelig 150 mg Film-coated tablet | GILEAD SCIENCES LIMITED | PLGB 11972/0032 |
| Anoro Ellipta 55 µg + 22 µg - Inhalation powder, pre-dispensed | GlaxoSmithKline UK Limited | PLGB 19494/0268 |
| Avamys 27.5 micrograms/spray - Nasal spray, suspension | GlaxoSmithKline UK Limited | PLGB 19494/0269 |
| Benlysta 120 mg - Powder for concentrate for solution for infusion | GlaxoSmithKline UK Limited | PLGB 19494/0270 |
| Benlysta 200 mg - Solution for injection | GlaxoSmithKline UK Limited | PLGB 19494/0271 |
| Benlysta 400 mg - Powder for concentrate for solution for infusion | GlaxoSmithKline UK Limited | PLGB 19494/0272 |
| Incruse Ellipta 55 micrograms - Inhalation powder, pre-dispensed | GlaxoSmithKline UK Limited | PLGB 19494/0273 |
| Integrilin 0.75 mg/ml - Solution for infusion | GlaxoSmithKline UK Limited | PLGB 19494/0274 |
| Integrilin 2 mg/ml - Solution for injection | GlaxoSmithKline UK Limited | PLGB 19494/0275 |
| Relvar Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed | GlaxoSmithKline UK Limited | PLGB 19494/0277 |
| Relvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed | GlaxoSmithKline UK Limited | PLGB 19494/0278 |
| Volibris 10 mg - Film-coated tablet | GlaxoSmithKline UK Limited | PLGB 19494/0281 |
| Volibris 5 mg - Film-coated tablet | GlaxoSmithKline UK Limited | PLGB 19494/0282 |
| Rotarix not less than 106.0 CCID50 - Oral suspension | GlaxoSmithKline UK Limited | PLGB 19494/0256 |
| Adjupanrix - Emulsion and suspension for emulsion for injection | GlaxoSmithKline UK Limited | PLGB 19494/0258 |
| Ambirix - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0259 |
| Cervarix - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0260 |
| Infanrix hexa - Powder and suspension for suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0261 |
| Shingrix - Powder and suspension for suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0263 |
| Twinrix Adult - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0265 |
| Twinrix Paediatric - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0266 |
| Fendrix 20 µg - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0267 |
| ALLI 60 mg Hard Capsules | GlaxoSmithKline Consumer Healthcare (UK) Trading Limited | PLGB 44673/0197 |
| Nucala 100 mg - Powder for solution for injection | GlaxoSmithKline UK Limited | PLGB 19494/0285 |
| Trelegy Ellipta 92 µg + 55 µg + 22 µg - Inhalation powder, pre-dispensed | GlaxoSmithKline UK Limited | PLGB 19494/0287 |
| Nucala 100 mg solution for injection in pre-filled pen | GlaxoSmithKline UK Limited | PLGB 19494/0290 |
| Nucala 100 mg solution for injection in pre-filled syringe | GlaxoSmithKline UK Limited | PLGB 19494/0291 |
| Dectova 10 mg/mL solution for infusion | GlaxoSmithKline UK Limited | PLGB 19494/0292 |
| Olanzapine Glenmark 20 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0305 |
| Olanzapine Glenmark 5 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0306 |
| Olanzapine Glenmark 7.5 mg - Tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0307 |
| Olanzapine Glenmark Europe 10 mg - Orodispersible tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0308 |
| Olanzapine Glenmark Europe 15 mg - Orodispersible tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0309 |
| Olanzapine Glenmark Europe 20 mg - Orodispersible tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0310 |
| Olanzapine Glenmark Europe 5 mg - Orodispersible tablet | Glenmark Arzneimittel GmbH, Germany | PLGB 25258/0311 |
| Cuprior 150 mg - film coated Tablet | Orphalan | PLGB 48003/0001 |
| Qutenza 179 mg - Cutaneous patch | Grunenthal GmbH | PLGB 04539/0043 |
| Zalviso 15 µg - Sublingual tablet | FGK REPRESENTATIVE SERVICE GMBH | PLGB 27682/0009 |
| Brintellix 10 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0296 |
| Brintellix 15 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0297 |
| Brintellix 20 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0298 |
| Bexsero - Suspension for injection | GlaxoSmithKline UK Limited | PLGB 19494/0288 |
| Menveo - Powder and solution for solution for injection | GlaxoSmithKline UK Limited | PLGB 19494/0289 |
| Epidyolex 100mg/ml Oral Solution | GW Research Ltd | PLGB 36772/0001 |
| Brintellix 20 mg/ml - Oral drops, solution | Lundbeck Limited | PLGB 00458/0299 |
| Brintellix 5 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0300 |
| Ebixa 10 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0301 |
| Ebixa 20 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0302 |
| Ebixa 5 mg + 10 mg + 15 mg + 20 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0303 |
| Ebixa 5 mg/pump actuation - Oral solution | Lundbeck Limited | PLGB 00458/0304 |
| Selincro 18 mg - Film-coated tablet | Lundbeck Limited | PLGB 00458/0305 |
| Ledaga 160 micrograms/g gel | Helsinn Birex Pharmaceuticals Ltd | PLGB 12333/0016 |
| Akynzeo 300 mg + 0.50 mg - Capsule, hard | Helsinn Birex Pharmaceuticals Ltd | PLGB 12333/0018 |
| Akynzeo 235 mg/0.25 mg powder for concentrate for solution for infusion | Helsinn Birex Pharmaceuticals Ltd | PLGB 12333/0017 |
| Aloxi 250 µg - Solution for injection | Helsinn Birex Pharmaceuticals Ltd | PLGB 12333/0014 |
| Aloxi 500 µg - Capsule, soft | Helsinn Birex Pharmaceuticals Ltd | PLGB 12333/0015 |
| Voriconazole Hikma 200 mg - Powder for solution for infusion | Hikma Farmaceutica (Portugal), S.A. | PLGB 15413/0094 |
| Lumark 80 GBq/mL radiopharmaceutical precursor, solution | I.D.B. Holland B.V. | PLGB 26616/0001 |
| Iclusig 15 mg - Film-coated tablet | Incyte Biosciences Distribution B.V. | PLGB 49635/0001 |
| Iclusig 30 mg - Film-coated tablet | Incyte Biosciences Distribution B.V. | PLGB 49635/0002 |
| Iclusig 45 mg - Film-coated tablet | Incyte Biosciences Distribution B.V. | PLGB 49635/0003 |
| RAVICTI 1.1 g/ml - Oral liquid | Immedica Pharma AB | PLGB 53487/0001 |
| Ammonaps 500 mg - Tablet | Immedica Pharma AB | PLGB 53487/0002 |
| Flebogamma DIF 100 mg/ml - Solution for infusion | Instituto Grifols, S.A. | PLGB 12930/0018 |
| Flebogamma DIF 50 mg/ml - Solution for infusion | Instituto Grifols, S.A. | PLGB 12930/0019 |
| VeraSeal 80 mg/ml + 500 IU/ml Solutions for sealant | Instituto Grifols, S.A. | PLGB 12930/0020 |
| OCALIVA 10 mg - Film-coated tablet | Intercept Pharma Ltd | PLGB 48025/0002 |
| OCALIVA 5 mg - Film-coated tablet | Intercept Pharma Ltd | PLGB 48025/0003 |
| CABOMETYX 20 mg - Film-coated tablet | Ipsen Pharma | PLGB 28247/0001 |
| CABOMETYX 40 mg - Film-coated tablet | Ipsen Pharma | PLGB 28247/0002 |
| CABOMETYX 60 mg - Film-coated tablet | Ipsen Pharma | PLGB 28247/0003 |
| Cometriq 20 mg - Capsule, hard | Ipsen Pharma | PLGB 28247/0004 |
| Cometriq 20 mg+80 mg - Capsule, hard | Ipsen Pharma | PLGB 28247/0005 |
| Increlex 10 mg / ml - Solution for injection | Ipsen Pharma | PLGB 28247/0006 |
| NutropinAq 10 mg/2 ml (30 IU) solution for injection | Ipsen Pharma | PLGB 28247/0007 |
| Xermelo 250 mg - Film-coated tablet | Ipsen Pharma | PLGB 28247/0008 |
| EndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solution 2ml | ITM Medical Isotopes GmbH | PLGB 45370/0001 |
| EndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solution 10ml | ITM Medical Isotopes GmbH | PLGB 45370/0002 |
| SYLVANT 100 mg - Powder for concentrate for solution for infusion | EUSA Pharma | PLGB 16445/0069 |
| SYLVANT 400 mg - Powder for concentrate for solution for infusion | EUSA Pharma | PLGB 16445/0070 |
| CRYSVITA 10 mg - Solution for injection | Kyowa Kirin Holdings B.V. | PLGB 50262/0001 |
| Remicade 100 mg - Powder for concentrate for solution for infusion | Janssen-Cilag Ltd | PLGB 00242/0657 |
| Simponi 100 mg - Solution for injection Pre-filled Pen | Janssen-Cilag Ltd | PLGB 00242/0658 |
| Simponi 50 mg - Solution for injection Pre-filled Pen | Janssen-Cilag Ltd | PLGB 00242/0659 |
| Simponi 50 mg - Solution for injection Pre-filled Syringe | Janssen-Cilag Ltd | PLGB 00242/0660 |
| Simponi 45 mg/0.45 mL solution for injection in pre-filled pen | Janssen-Cilag Ltd | PLGB 00242/0661 |
| Dacogen 50 mg - Powder for concentrate for solution for infusion | Janssen-Cilag Ltd | PLGB 00242/0662 |
| Opsumit 10 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0663 |
| Symtuza 800 mg/150 mg/200 mg/10 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0664 |
| Tremfya 100 mg Solution for injection in pre-filled pen | Janssen-Cilag Ltd | PLGB 00242/0665 |
| Uptravi 200 mircogram - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0666 |
| Uptravi 400 microgram - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0667 |
| Uptravi 600 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0668 |
| Uptravi 800 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0669 |
| Uptravi 1000 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0670 |
| Uptravi 1200 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0671 |
| Uptravi 1400 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0672 |
| Uptravi 1600 microgram Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0673 |
| Zavesca 100 mg - Capsule, hard | Janssen-Cilag Ltd | PLGB 00242/0674 |
| Caelyx pegylated liposomal 2mg/ml concentrate for solution for infusion | Janssen-Cilag Ltd | PLGB 00242/0675 |
| Darzalex 20 mg/ml - Concentrate for solution for infusion | Janssen-Cilag Ltd | PLGB 00242/0676 |
| Darzalex 1800mg solution for injection | Janssen-Cilag Ltd | PLGB 00242/0677 |
| Edurant 25 mg Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0678 |
| EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch | Janssen-Cilag Ltd | PLGB 00242/0679 |
| INTELENCE 100 mg - Tablet | Janssen-Cilag Ltd | PLGB 00242/0681 |
| INTELENCE 200 mg - Tablet | Janssen-Cilag Ltd | PLGB 00242/0682 |
| Imbruvica 140 mg - Capsule, hard | Janssen-Cilag Ltd | PLGB 00242/0687 |
| Imbruvica 140 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0688 |
| Imbruvica 280 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0689 |
| Imbruvica 420 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0690 |
| Imbruvica 560 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0691 |
| Invega 3 mg - Prolonged-release tablet | Janssen-Cilag Ltd | PLGB 00242/0683 |
| Invega 6 mg - Prolonged-release tablet | Janssen-Cilag Ltd | PLGB 00242/0684 |
| Invega 9 mg - Prolonged-release tablet | Janssen-Cilag Ltd | PLGB 00242/0685 |
| Invokana 100 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0698 |
| Invokana 300 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0699 |
| Prezista 100 mg/ml - Oral suspension | Janssen-Cilag Ltd | PLGB 00242/0692 |
| Prezista 150 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0694 |
| Prezista 400 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0695 |
| Prezista 600 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0696 |
| Prezista 75 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0693 |
| Prezista 800 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0697 |
| Rezolsta 800 mg /150 mg Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0704 |
| SIRTURO 100 mg Tablet | Janssen-Cilag Ltd | PLGB 00242/0705 |
| Stelara 130 mg - Concentrate for solution for infusion | Janssen-Cilag Ltd | PLGB 00242/0703 |
| Stelara 45 mg - Solution for injection | Janssen-Cilag Ltd | PLGB 00242/0700 |
| Stelara 45 mg - Solution for injection in pre-filled syringe | Janssen-Cilag Ltd | PLGB 00242/0701 |
| Stelara 90 mg - Solution for injection in pre-filled syringe | Janssen-Cilag Ltd | PLGB 00242/0702 |
| CRYSVITA 20 mg - Solution for injection | Kyowa Kirin Holdings B.V. | PLGB 50262/0002 |
| CRYSVITA 30 mg - Solution for injection | Kyowa Kirin Holdings B.V. | PLGB 50262/0003 |
| Trevicta 175 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0712 |
| Trevicta 263 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0713 |
| Trevicta 350 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0714 |
| Trevicta 525 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0715 |
| VELCADE 3.5 mg - Powder for solution for injection | Janssen-Cilag Ltd | PLGB 00242/0707 |
| Xeplion 150 mg - Prolonged-release suspension for injection | Jannsen-Cilag Ltd | PLGB 00242/00711 |
| Moventig 12.5 mg - Film-coated tablet | Kyowa Kirin Holdings B.V. | PLGB 50262/0004 |
| Moventig 25 mg - Film-coated tablet | Kyowa Kirin Holdings B.V. | PLGB 50262/0005 |
| Vokanamet 50 mg/1000 mg Film-coated tablet | Jannsen-Cilag Ltd | PLGB 00242/0717 |
| Vokanamet 50 mg /850 mg Film-coated tablet | Jannsen-Cilag Ltd | PLGB 00242/0716 |
| Xeplion 100 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0710 |
| Xeplion 50 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0708 |
| Xeplion 75 mg - Prolonged-release suspension for injection | Janssen-Cilag Ltd | PLGB 00242/0709 |
| Zytiga 250 mg - Tablet | Janssen-Cilag Ltd | PLGB 00242/0718 |
| Zytiga 500 mg - Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0719 |
| PecFent 100 µg / spray - Nasal spray, solution | Kyowa Kirin Holdings B.V. | PLGB 50262/0006 |
| Tracleer 62.5 mg Film-coated tablet | Janssen-Cilag | PLGB 00242/0722 |
| Tracleer 125 mg Film-coated tablet | Janssen-Cilag | PLGB 00242/0723 |
| Erleada 60mg Film-coated tablet | Janssen-Cilag Ltd | PLGB 00242/0720 |
| Vyxeos 2.2 mg/ml + 5 mg/ml - Powder for concentrate for solution for infusion | Jazz Pharmaceuticals UK Limited | PLGB 31626/0004 |
| PecFent 400 µg / spray - Nasal spray, solution | Kyowa Kirin Holdings B.V. | PLGB 50262/0007 |
| Atazanavir Krka 150 mg Capsules | KRKA, d.d., Novo mesto | PLGB 01656/0287 |
| Atazanavir Krka 200 mg Capsules | KRKA, d.d., Novo mesto | PLGB 01656/0288 |
| Atazanavir Krka 300 mg Capsules | KRKA, d.d., Novo mesto | PLGB 01656/0289 |
| Clopidogrel Krka d.d. 75 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0290 |
| Darunavir Krka 400 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0291 |
| Darunavir Krka 600 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0292 |
| Darunavir Krka 800 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0293 |
| Darunavir Krka d.d. 400 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0294 |
| Darunavir Krka d.d. 600 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0295 |
| Darunavir Krka d.d. 800 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0296 |
| Dasselta 5 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0297 |
| Ecansya 150 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0298 |
| Ecansya 300 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0299 |
| Ecansya 500 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0300 |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg + 200 mg + 245 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0301 |
| Emtricitabine/Tenofovir disoproxil Krka 200 mg + 245 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0302 |
| Emtricitabine/tenofovir disoproxil Krka d.d. 200 mg + 245 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0303 |
| Enyglid 0.5 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0304 |
| Enyglid 1 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0305 |
| Enyglid 2 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0306 |
| Febuxostat Krka 80mg Capsules | KRKA, d.d., Novo mesto | PLGB 01656/0307 |
| Febuxostat Krka 120mg Capsules | KRKA, d.d., Novo mesto | PLGB 01656/0308 |
| Ifirmacombi 150 mg + 12.5 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0309 |
| Ifirmacombi 300 mg + 12.5 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0310 |
| Ifirmacombi 300 mg + 25 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0311 |
| Ifirmasta 150 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0312 |
| Ifirmasta 300 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0313 |
| Ifirmasta 75 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0314 |
| Marixino 10 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0315 |
| Marixino 20 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0316 |
| Nimvastid 1.5 mg - Capsule, hard | KRKA, d.d., Novo mesto | PLGB 01656/0317 |
| Nimvastid 1.5 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0318 |
| Nimvastid 3 mg - Capsule, hard | KRKA, d.d., Novo mesto | PLGB 01656/0319 |
| Nimvastid 3 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0320 |
| Nimvastid 4.5 mg - Capsule, hard | KRKA, d.d., Novo mesto | PLGB 01656/0321 |
| Nimvastid 4.5 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0322 |
| Nimvastid 6 mg - Capsule, hard | KRKA, d.d., Novo mesto | PLGB 01656/0323 |
| Nimvastid 6 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0324 |
| Oprymea 0.088 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0325 |
| Oprymea 0.18 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0326 |
| Oprymea 0.26 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0327 |
| Oprymea 0.26 mg + 0.52 mg + 1.05 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0328 |
| Oprymea 0.35 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0329 |
| Oprymea 0.52 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0330 |
| Oprymea 0.7 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0331 |
| Oprymea 1.05 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0332 |
| Oprymea 1.1 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0333 |
| Oprymea 1.57 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0334 |
| Oprymea 2.1 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0335 |
| Oprymea 2.62 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0336 |
| Oprymea 3.15 mg - Prolonged-release tablet | KRKA, d.d., Novo mesto | PLGB 01656/0337 |
| Pemetrexed Krka 100 mg - Powder for concentrate for solution for infusion | KRKA, d.d., Novo mesto | PLGB 01656/0338 |
| Pemetrexed Krka 500 mg - Powder for concentrate for solution for infusion | KRKA, d.d., Novo mesto | PLGB 01656/0339 |
| Repaglinide Krka 0.5 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0340 |
| Repaglinide Krka 1 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0341 |
| Repaglinide Krka 2 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0342 |
| Tolucombi 40 mg/12.5mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0343 |
| Tolucombi 80 mg/12.5mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0344 |
| Tolucombi 80 mg/25 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0345 |
| Tolura 20 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0346 |
| Tolura 40 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0347 |
| Tolura 80 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0348 |
| Vizarsin 100 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0349 |
| Vizarsin 100 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0350 |
| Vizarsin 25 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0351 |
| Vizarsin 25 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0352 |
| Vizarsin 50 mg - Film-coated tablet | KRKA, d.d., Novo mesto | PLGB 01656/0353 |
| Vizarsin 50 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0354 |
| Zalasta 10 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0355 |
| Zalasta 10 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0356 |
| Zalasta 15 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0357 |
| Zalasta 15 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0358 |
| Zalasta 2.5 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0359 |
| Zalasta 20 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0360 |
| Zalasta 20 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0361 |
| Zalasta 5 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0362 |
| Zalasta 5 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0363 |
| Zalasta 7.5 mg - Orodispersible tablet | KRKA, d.d., Novo mesto | PLGB 01656/0364 |
| Zalasta 7.5 mg - Tablet | KRKA, d.d., Novo mesto | PLGB 01656/0365 |
| POTELIGEO 4 mg/ml - Concentrate for solution for infusion | Kyowa Kirin Holdings B.V. | PLGB 50262/0008 |
| Sancuso 3.1 mg / 24 h - Transdermal patch | Kyowa Kirin Holdings B.V. | PLGB 50262/0009 |
| Sixmo 74.2mg Impant | L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. | PLGB 16046/0027 |
| Giapreza 2.5 mg/ml Concentrate for solution for infusion | LA JOLLA PHARMACEUTICAL II BV | PLGB 49109/0002 |
| Neofordex 40 mg - Tablet | Laboratoires CTRS | PLGB 44776/0001 |
| Orphacol 250 mg - Capsule, hard | Laboratoires CTRS | PLGB 44776/0002 |
| Orphacol 50 mg - Capsule, hard | Laboratoires CTRS | PLGB 44776/0003 |
| Pravafenix 160 mg + 40 mg - Capsule, hard | Laboratoires SMB s.a. | PLGB 15190/0034 |
| Luminity 150 µl / ml - Gas and solvent for dispersion for injection/infusion | Lantheus MI UK Ltd. | PLGB 34258/0003 |
| Chenodeoxycholic acid Leadiant 250 mg - Capsule, hard | Leadiant Biosciences Ltd | PLGB 44975/0001 |
| ellaOne 30 mg - Film-coated tablet | Laboratoire HRA Pharma | PLGB 17836/0011 |
| ellaOne 30 mg - Tablet | Laboratoire HRA Pharma | PLGB 17836/0012 |
| Ketoconazole HRA 200 mg - Tablet | HRA Pharma Rare Diseases | PLGB 51757/0002 |
| Lysodren 500 mg - Tablet | HRA Pharma Rare Diseases | PLGB 51757/0003 |
| Kyntheum 210 mg - Solution for injection | LEO Pharma AS/S | PLGB 05293/0171 |
| Protopic 0.1% - Ointment | LEO Pharma AS/S | PLGB 05293/0183 |
| Protopic 0.03% - Ointment | LEO Pharma AS/S | PLGB 05293/0184 |
| Lonsurf 15 mg + 6.14 mg - Film-coated tablet | Les Laboratoires Servier | PLGB 05815/0112 |
| Lonsurf 20 mg + 8.19 mg - Film-coated tablet | Les Laboratoires Servier | PLGB 05815/0113 |
| Oncaspar 750 U/ml - Powder for solution for injection/infusion | Les Laboratoires Servier | PLGB 05815/0114 |
| Oncaspar 750 U/ml - Solution for injection/infusion | Les Laboratoires Servier | PLGB 05815/0115 |
| Onivyde pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion | Les Laboratoires Servier | PLGB 05815/0111 |
| Procoralan 5 mg - Film-coated tablet | Les Laboratoires Servier | PLGB 05815/0116 |
| Procoralan 7.5 mg - Film-coated tablet | Les Laboratoires Servier | PLGB 05815/0117 |
| Valdoxan 25 mg - Film-coated tablet | Les Laboratoires Servier | PLGB 05815/0118 |
| Pixuvri 29mg powder for concentrate for solution for infusion | Les Laboratoires Servier | PLGB 05815/0119 |
| Neuraceq 300 MBq - Solution for injection | Life Radiopharma Berlin GmbH | PLGB 50691/0001 |
| INOmax 400 ppm - Inhalation gas | Linde Healthcare AB | PLGB 43800/0001 |
| INOmax 800 ppm - Inhalation gas | Linde Healthcare AB | PLGB 43800/0002 |
| Deferiprone Lipomed 500 mg - Film-coated tablet | Lipomed GmbH | PLGB 19745/0005 |
| Litak 2 mg/ml - Solution for injection | Lipomed GmbH | PLGB 19745/0006 |
| Namuscla 167mg Capsule, hard | Lupin Europe GmBH | PLGB 54289/0001 |